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Vibrational spectroscopy, based on either infrared absorption or Raman scattering, has attracted 
increasing attention for biomedical applications. Proof of concept explorations for diagnosis of oral 
potentially malignant disorders and cancer are reviewed, and recent advances critically appraised. 
Specific examples of applications of Raman microspectroscopy for analysis of histological, cytological 
and saliva samples are presented for illustrative purposes, and the future prospects, ultimately for 
routine, chairside in vivo screening are discussed.  
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1. Introduction 
Oral cancers are prevalent worldwide, and, in 2018, had estimated age-standardised incidence rate 
(World) for both sexes, all ages, of 4 per 100,000 population [1]. Critically, carcinoma of the oral 
cavity has a very poor overall 5 year survival rate of approximately 50%, due mostly to late stage 
diagnosis [2]. Oral squamous cell carcinoma (OSCC) is the predominant malignancy and is more 
common in males than females, having a ratio of 1.5:1, and in older persons (aged 50 or over) [3]. 
Nevertheless, there are currently changes in the trend, manifest as an increase in incidence in young 
persons, which may be due to HPV infection as opposed to the traditional risk factors such as 
smoking and tobacco [4].  
OSCC arises in the squamous epithelium and, like all cancers, is a multi-step process in which cells 
acquire mutations that allow them to evade immune surveillance and divide uncontrollably. It can 
manifest as an endophytic (inward) or exophytic (outward) growth, which can either arise de novo or 
from oral potentially malignant disorders (OPMD), typically either from a leukoplakia (white plaques 
of questionable risk having excluded (other) known diseases or disorders that carry no increased risk 
for cancer), erythroplakia (red patch) or erythroleukoplakia (mixed red and white patch) [5]. Most 
OPMD are symptomless, but some may be associated with bleeding, or soreness. The risk of 
malignant transformation of these OPMD is determined by a numbers of factors, with the degree of 
dysplasia being the most significant. The current recommendation for management of OMPDs is that 
risk factors are addressed and moderate and severely dysplastic oral lesions are excised, while 
OPMD with no dysplasia is usually followed up annually, mild dysplasia reviewed every 6-12 months 
OSCC usually present clinically as a persistent ulcer or hard lump in the oral mucosa, but leukoplakias, 
erythroplakias and erythroleukoplakias may be found, on biopsy, to harbour OSCC. Patients with 
advanced OSCC may present with symptoms like difficulty of swallowing or speaking, or swollen lymph 
nodes in the neck [6]. Following appropriate referral, any suspicious lesion is biopsied and sent for 
histopathological examination, which is the gold standard for oral cancer diagnosis. After the initial 
diagnosis of OSCC is made, the cancer staging to determine the tumour size,  presence of lymph node 
or distant metastasis is determined by the use of imaging techniques such as MRI, CT, and PET scans 
[7]. Cancer stage at diagnosis is the single most important prognostic factor.  
Early diagnosis is therefore critical in the management of oral cancer, [8].The low rate of early 
diagnosis of OSCC can be partially attributed to the late recognition of such OPMDs prior to 
malignant transformation [9, 10]. Visual observation of mucosal abnormalities by a dentist or 
hygienist is the most common starting point of diagnosis, and therefore optical methods play a 
potential role, currently, and in prospective advances in methodologies for early stage diagnosis 
[11]. In particular, the vibrational spectroscopic techniques of infrared (IR) absorption and Raman 
scattering spectroscopies promise the potential for objective, label free, in vivo or ex vivo analysis, 
which is based on the molecular content of the sample, rather than simply the morphological 
appearance of abnormalities, a process which can be highly subjective. 
This paper describes research efforts towards the development and validation of vibrational 
spectroscopic methods, typically employing commercially available spectroscopic instrumentation, 
for the early identification of abnormalities in the oral cavity in tissue, cells and saliva, reviewing 
literature to date. Specific examples of the application of Raman microspectroscopy, based on work 
of the authors, are presented. Future perspectives are presented, also in the context of the potential 
of the technique for in vivo screening and monitoring. 
2. Histopathology 
Both IR and Raman spectroscopies provide a biochemical “fingerprint” of the sample under 
interrogation, on the basis of the distinctive vibrations of the constituent molecules. They are, 
however, fundamentally different techniques, as evidenced starkly by the fact that, while Raman 
spectroscopy is commonly carried out in the visible or near infrared region of the spectrum, IR 
spectroscopy is commonly carried out in the mid-infrared region. Both can be carried out in the 
microscopic mode (for further information and comparison of methodologies, see for example [12]), 
in which, intrinsic limitations to spatial resolution imply that Raman can probe areas of <1 m, 
whereas IR is typically limited to ~10 m. In the field of spectro-histopathology [13], however, the 
requirement to rapidly scan large areas of tissue probably currently favour the use of IR rather than 
Raman spectroscopy. 
A number of early stage studies demonstrated that Fourier Transform IR (FTIR) microspectroscopy, 
can be employed to effectively differentiate abnormal and normal states in excised oral tissues, and 
pointed towards the differences in biochemical composition underpinning the differentiation. 
Schultz et al. [14] undertook a study which attempted to identify the biochemical differences 
between well and poorly differentiated oral/oropharyngeal SCC, and demonstrated that spectral 
features of DNA and keratin can provide the basis for differentiation of clinically classified normal 
and OSCC biopsies. The prominence of keratin structures in OSCC samples was also explored [15]. 
Wu et al. [16] demonstrated that normal and malignant oral tissues can be discriminated on the 
basis of the relative lipid and protein content of fresh oral tissue samples. Comparing tissue from 
normal subgingival sites and OSCC, Fukuyama et al. [17] demonstrated that the spectral 
characteristics of normal tissue are more strongly influenced by contributions of keratin and 
collagen, compared to the spectra of abnormal samples. Increasingly sophisticated FTIR 
spectroscopic imaging methods have provided the capacity to explore different aspects of oral 
cancer and cancer development. By generating 3D infrared chemical maps, Bruni et al. [18] showed 
that proliferating and regressive states of head and neck tumours can be identified. A study using 
FTIR spectroscopy to explore chemopreventive effects of drug-loaded nanoparticles on oral 
carcinogenesis in animal models has also been reported [19].  
Applications of Raman spectroscopy in oral cancer diagnostics began with the analysis of normal and 
dysplastic tissue in a rat model by Bakker Schut et al. [20], who achieved sensitivity and specificity of 
100% for dysplasia induced in the palate by topical application of the carcinogen 4-nitroquinoline 1-
oxide. There followed a study of human oral cancer biopsies by Venkatakrishna et al. [21] who 
obtained an average classification efficiency of 88%. A study carried out by Krishna et al. in 2004 [21] 
demonstrated the applicability of formalin-fixed oral tissues for optical pathology, revealing 
significant differences in the epithelial region of normal and malignant samples, arising from the 
protein composition, conformational/structural changes, and possible increase in protein content in 
malignant epithelia. In 2006, Malini et al. [22] demonstrated the efficacy of Raman spectroscopic 
methods in discriminating normal, cancerous, precancerous, and inflammatory conditions. Lipid rich 
features in normal conditions and prominent protein features in tumours and other pathological 
conditions were observed. Classification between different groups using multivariate statistical 
methods produced 100% sensitivity and specificity [22]. Raman mapping of tissue sections further 
elucidated biochemical changes within different epithelial layers, which are associated with disease 
onset [23, 24]. A study by Sunder et al. [25] demonstrated that oral carcinomas of different 
pathological grades can also be differentiated on the basis of the relative intensities of bands 
associated with lipids and proteins. 
Cals et al. undertook a study of excised tongue tissue samples (11 OCSCC and 14 normal) of 10 
patients, to establish multivariate classification models based on Principal Components Analysis 
(PCA) – Linear Discriminant Analysis (LDA), a binary tumour versus non-tumorous tissue model 
showing an accuracy of 91%, sensitivity of 100%, and specificity of 78% [26]. A further study 
specifically explored samples of OSCC from excised tongue tissue (44 samples from 21 patients) and 
produced a range of anatomically subclassified spectra, characteristic of OSCC, surface squamous 
epithelium, muscle, adipose tissue, connective tissue, gland, and nerve [27]. Least squares fitting 
each characteristic spectrum with combinations of biochemical constituent spectra revealed that the 
carbohydrates, proteins and amino acids content was the strongest discriminator between OSCC and 
healthy tissue. Jeng et al. explored the use of Raman microspectroscopy to differentiate excised 
tumour and normal tissue samples from different anatomical regions; the tongue, the buccal 
mucosa, and the gingiva of the oral mucosa [28]. Although a high degree of classification was 
observed for all sites, analysis of the gingiva was seen to yield the highest values of accuracy (91%), 
sensitivity (92%) and specificity (91%). In addition to protein and amino acid, variations of beta-
carotene content were identified as a potential biomolecular marker of oral cancer. Jeng et al. 
compared the performance of the classifier algorithms, PCA - LDA and PCA - quadratic discriminant 
analysis (QDA), the latter performing better, while Yu et al. applied deep convolutional neural 
networks to classify squamous cell carcinoma and non-tumorous tissue of the tongue, achieving high 
values of sensitivity (99.31%) and specificity (94.44%) [29]. 
Although there have been numerous proof-of-concept studies to demonstrate the potential of both 
IR and Raman spectroscopies for spectro-histopathology, an issue which continues to arise is that of 
sample presentation [30, 31]. Although unadulterated, fresh tissue biopsies are preferable, the gold-
standard histopathological method employs a process of formalin fixation followed by paraffin wax 
embedding. The tissue is first dehydrated and then infiltrated with paraffin wax, such that the 
samples are stabilised and can be stored for years. These formalin fixed paraffin preserved (FFPP) 
archival tissue libraries can potentially be a vast resource for retrospective studies of patient history 
and disease progression. Unfortunately, the lipid-like paraffin wax can interfere with either FTIR or 
Raman spectroscopic analysis [32, 33]. A number of different approaches to remove the paraffin wax 
have been tested. The normal clinical protocols of chemical dewaxing have been demonstrated to be 
only partially effective [33], and also dependent on the clinical pathology [34], while so called “digital 
dewaxing” has been shown to be only partially successful [35]. Toward high throughput automated 
analysis, Pallua et al. [36] demonstrated that high quality FTIR microspectroscopic images can be 
obtained from formalin-fixed paraffin-embedded tissue microarray sections, providing molecular 
level information as the basis for diagnosis. However, the symmetrical C-C vibrations of the wax 
molecule backbone are particularly strong in Raman spectroscopy, and, as the embedded wax is 
microcrystalline, and the source laser usually polarised, it has been shown that the difficulties in the 
subtraction of the wax contributions to the Raman spectra of tissue are due to the continuous 
variability of the spectra [37]. However, by employing a matrix of (300) reference spectra of the wax, 
Ibrahim et al. demonstrated the effective removal of its contamination, as well as that of the glass 
substrate (Figure 1), from the spectra of both epithelial and connective tissue of oral biopsies (Figure 
2) [37].  
 
Figure 1: Mean Raman spectra of epithelial and connective tissue before (left) and after (right) 
digital wax removal. Shading denotes the standard deviation [37]. 
 
Figure 2: Representative H&E images showing the regions of epithelium (darkly stained) and 
connective tissue (lightly stained) [37]. 
Using the digital processing protocol, Ibrahim explored the potential of vibrational spectroscopy, 
specifically Raman, to monitor the early stage progression of oral cancer [38]. OSCC is commonly 
preceded by a range of cell and tissue alterations, termed dysplasia, which indicate an increased risk 
of malignant transformation. Dysplasia is classified according to severity into mild, moderate, 
severe/ carcinoma in situ. The initial study therefore undertook to attempt to discriminate 
between mild, moderate and severe dysplasia in FFPP tissues from biopsies of 4 patients who 
had undergone multiple biopsies over time [38]. Two maps were taken for each pathology, one 
of epithelium and one of connective tissue. Each consisted of 200 spectral points (~1 m) taken 
at 10 μm intervals. Using a Partial Least Squares, Discriminant Analysis (PLSDA) approach, high 
degrees of sensitivity and specificity were achieved for classification of each grade of dysplasia, 
in both tissue regions (Table 1). 
 
Table 1: Sensitivity and specificity values obtained for the PLSDA classification model 
Expanding the study to a cohort of 57 patients, the spectroscopic differences between benign, 
mild, moderate, severely dysplastic and OSCC FFPP tissues were explored [38, 39]. Although the 
sensitivities and specificities for each grade of dysplasia were in some cases rather low (Table 2), 
the performance was considerably improved by grouping the mild and moderate groups (Table 
3), although clinically, mild is considered low risk while moderate and severe dysplasia are 
considered high risk. 
 
Table 2: Sensitivity and specificity values obtained from PLSDA classification of epithelial tissue.  
 
Table 3:  PLSDA classification of epithelial tissue combining the mild and moderate groups 
As the study was based on a heterogeneous group of patients with different gender, age, habits, 
medical histories and lesion clinical features, the relatively poor performance of the discriminative 
models prompted an investigation of the potential influence of patient factors and clinical features 
on Raman classification, such as smoking, alcohol consumption, and anatomical site Tobacco 
smoke contains carcinogens and has a well established role in the development of both 
dysplastic [40] and malignant [41] oral lesions. Similarly, alcohol consumption has been 
associated with the development of both oral dysplasia [40] and cancer [41]. The incidence of 
oral cancer is higher in males than females [42, 43], which is likely due to habits such as smoking 
and alcohol consumption rather than a genetic predisposition, although the prognosis is the 
same [44]. Gender was not found to have an association with the development of oral dysplastic 
lesions [40]. Further variability can arise because of the different sites of anatomical origin of 
the lesion. Oral cancer refers to any cancer in the oral cavity proper which includes; the tongue, 
labial and buccal mucosa, palate, gingiva, alveolar ridges and floor of the mouth. These areas 
vary in degree of keratinisation, vascularity and lymphatic drainage [44] and thus anatomic site 
may also influence the spectroscopic signatures upon which a classification is to be based.  
Ibrahim et al. used patient metadata to subdivide the sample spectra, regardless of 
histopathological diagnosis, into groups according to gender, smoking habits, alcohol 
consumption and site of lesion [39]. The analysis indicated no discrimination based on gender, or 
alcohol consumption. Although the lesions came from different anatomical sites in the oral cavity, 
including the tongue, buccal mucosa, soft palate, hard palate and labial mucosa, the PLSDA 
classification results were very varied and inclusive, probably due to the low number of samples 
per site, although grouping according to keratinised (tongue and hard palate) and non-
keratinised (soft palate, buccal and labial mucosa) did show some degree of discrimination. A 
degree of discrimination was also evident in the epithelia of 3 groups; non-smoker, ex-smokers 
(previous smokers) and smokers. 
Notably, all the pathologies showed the presence of inflammation, increasingly so with 
increasing severity of dysplasia, consistent with a previous study that has shown increasing 
inflammatory cell infiltration with increasing severity of oral dysplasia and SCC [45]. PLSDA 
indicated a high degree of sensitivity and specificity for discrimination of inflamed vs non-
inflamed for all the pathologies combined, in both epithelial (68% and 70%), and connective 
tissue (77% and 86%). The presence of inflammation in the tumour microenvironment has been 
well documented [46, 47] and is due to multiple factors. The environmental factors that prompt 
carcinogenesis, such as alcohol and smoking, have been shown to trigger an inflammatory 
response [48]. Furthermore, the tumour cells release inflammatory mediators which generate 
an inflammatory microenvironment that promotes cancer growth, invasion and metastasis [49]. 
A study looking at OSCC surgical margins found that inflamed connective tissue was more likely 
to misclassify with SCC than non-inflamed connective tissue [50]. The presence of inflammation, 
particularly in the connective tissue of biopsies, is therefore potentially the most profound 
factor which may confound the diagnostic accuracy of the technique. 
3. Cytology:  
Oral exfoliative cytology could potentially offer a minimally invasive means of monitoring dysplastic 
lesions in the oral cavity. Dysplastic and cancerous cells tend to have fewer and weaker connections 
to each other and to their neighbouring normal cells in the surrounding tissue and thus can easily be 
collected from the surface of the lesion. Oral brush biopsy is a well-tolerated, minimally invasive and 
safe method for harvesting cells from the oral cavity but oral cytology has not been widely adopted 
because of poor sensitivity for identification of dysplasia and cancer [51]. Other techniques, such as 
DNA analysis and molecular markers, such as melanoma associated antigen A (MAGE-A), lamin-5, 
Tenascin-C and epidermal growth factor receptor (EGFR), have been shown to improve the sensitivity 
and specificity of oral cytology [52]. In addition, as oral brush biopsy detects only cellular changes, a 
surgical biopsy coupled with histopathological assessment must be performed for definitive diagnosis 
of oral lesions. While cancerous cells can be collected from the surface, this does not constitute a 
diagnosis, which requires histological proof of breach of basement membrane. Despite this, brush 
biopsy may be very useful for patients with multiple oral lesions or for monitoring OPMDs 
A limited number of FTIR microspectroscopy studies have been reported, demonstrating the feasibility 
of diagnosis of oral cancers using single exfoliated cells prepared by cyto-centrifugation onto low e 
microscope slides [53–57]. Papamarkakis et al. demonstrated that FTIR microspectroscopy could 
classify oral cells according to anatomical site and that the compositional changes were attributed to 
the expression of keratins in the cells of the tongue and to the expression of collagen in the cells of 
the floor of the mouth [54]. In addition, samples from patients with malignancy associated 
abnormalities were observed to be spectrally similar to a sample from a patient with oral squamous 
cell carcinoma, and spectrally distinct from samples from healthy volunteers. Spectral differences in 
oral cells infected with the herpes simplex virus were also reported. Further studies from the same 
group showed that spectra from exfoliated cells from healthy volunteers could be discriminated from 
exfoliated cells from patients with oral dysplasia and cancer [55–57]. 
Similarly, only a limited number of Raman microspectroscopy studies have focussed on oral exfoliated 
cells. Sahu et al. [58] demonstrated discrimination between patients with oral cancer and healthy 
volunteers based on increased DNA and differences in protein secondary structure using pellets of 
oral exfoliated cells and the work was extended to detection of OPMDs [59]. Behl et al. [60] reported 
a new method for Raman microspectroscopy of single oral exfoliated cells prepared as liquid based 
cytology samples onto glass slides. A complete methodology incorporating sample collection, sample 
preparation, spectral acquisition and data pre-processing and analysis was developed (Figure 3). 
 
Figure 3: Optimised protocol for the Raman microspectroscopic study of oral exfoliated cells [60]. 
Further work by Behl et al. [61] analysed brush biopsy cytological samples from healthy donors and 
from patients with OPMDs, leukoplakia, erythroplakia and erythroleukoplakia, showing mild, 
moderate or severe dysplasia on histological analysis. Sensitivities of 94% and 86% and specificity of 
85% were achieved for discrimination between oral exfoliated cells from healthy donors and from 
patients with OPMDs, for spectra recorded from the cytoplasm and nucleus respectively, as shown in 
Figure 4, for the example of cytoplasm. 
 
Figure 4: PLS-DA predictive model for cytoplasm (normal vs lesion) a) score plot, b) Latent variable 1, 
c) predictive model and d) confusion matrix [61]. 
The discrimination was observed to be mainly based on lipidic contributions from the OPMD samples. 
This could be attributed to the fact that, during cell division, cells need energy, and this requirement 
is fulfilled by upregulating the lipid metabolism within the cell. Key spectroscopic features which were 
seen to be prominent in the PCA differentiation of healthy donors and from patients with OPMDs are 
identifiable in the Raman spectra of palmitic acid and C14-Ceramide (Figure 5). It is known that, if 
ceramide synthesis is mediated by a de-novo pathway, it condenses serine and palmitoyl-CoA (beta-
oxidised form of palmitic acid) as precursors in the endoplasmic reticulum [62]. It was demonstrated 
that the differentiating PCA loading, in the region 600-1400 cm-1, could be well fitted by a weighted 
difference of the spectra of palmitic acid and C14-Ceramide. Sphingolipids such as ceramides and 
sphingosine are building blocks for the eukaryotic plasma membrane. They have an important role to 
play in intra- or intercellular messengers, signal transduction, inflammation, angiogenesis, metabolic 
syndrome, neurodegeneration, and cancer/cancer therapy [63]. In mammalian cells, there are >28 
enzymes for ceramide metabolism and about >200 distinct structures. Through this explorative study, 
although there are many other contributing factors to the differentiating loading which were not 
fitted, it was successfully demonstrated that ceramides may play an important role in the 
discrimination of OPMD samples from healthy volunteer samples using Raman microspectroscopy and 
could therefore act as a spectral marker. Furthermore, this study also indicated that, in OPMDs, 
ceramide concentration increases in the cell, allowing differentiation of healthy volunteer samples 
from the OPMD patient samples. 
 
Figure 5: Loading of differentiating principal component for healthy volunteer samples and dysplasia 
samples indicating bands at 1065 and 1130 cm-1, also observed in the Raman spectra of C14-ceramide 
and palmitic acid  
The study also investigated the influence of age, gender, anatomical site, smoking and alcohol 
consumption on the classification model. Age, gender, smoking and alcohol consumption were not 
found to be confounding factors whereas anatomical site was found to influence the classification 
model. Spectra from gingiva and alveolar mucosa were found to be different to spectra from buccal 
mucosa and ventral surface of the tongue (Figure 6). As both gingiva and alveolar mucosa are rich in 
lipids such as ceramides, saturated fatty acids and cholesterol, which act as an antibacterial barrier 
against infection, cells from these sites showed a similar lipidic spectral profile to cells from OPMDs. 
Thus, it was concluded that future studies should use separate classification models for buccal mucosa 
/ tongue and for gingiva / alveolar mucosa, and notably, a PLS-DA model based only on buccal mucosa 
achieved sensitivities and specificities as high as 99% [61]. 
 
Figure 6: a) PLS-DA score plot for nuclear spectra from healthy donors (normal) vs patients (lesions), 
b) depicting anatomical sites [61]. 
Field cancerisation, which can result in multiple OPMDs and in second primary tumours and 
recurrences, has also been investigated in oral cytology samples [59, 64]. In the studies of pellets of 
exfoliated cells, Sahu et al. observed an overlap of spectra of cells from contralateral normal sites and 
spectra from cells from tumour sites in oral cancer patients, indicative of field cancerisation [59]. In 
the study of Behl et al., oral exfoliated cells were collected from healthy volunteers and from patients 
with OPMDs, both from the lesion and from contralateral clinically normal mucosa. The study showed 
that the contralateral normal samples could be classified as spectrally different from the healthy 
volunteer samples and showed spectral features similar to the lesion samples, particularly in patients 
who had developed multiple lesions [64]. The effect of smoking, alcohol consumption, degree of 
dysplasia and gender were explored to understand the factors contributing to the spectral overlap 
between lesion samples and contralateral normal samples but none of these were found to be 
confounding factors. 
4. BioFluid analysis: 
As an alternative to histological and/or cytological biopsies, bodily fluids (e.g. plasma, serum, saliva 
or urine) are emerging as an important source of samples for disease diagnosis and therapeutic 
monitoring, as their collection is relatively simple, largely non-invasive, and cost effective [65–69] 
and analysis of biofluids using IR and Raman spectroscopies for diagnostic applications has become 
increasingly prevalent [70–74]. However, diagnosis based on biofluids does suffer from limitations, 
such as low analyte concentration, longer acquisition time, and is prone to experimental errors. In 
the case of FTIR spectroscopy, the relatively strong water absorption means that samples are usually 
dried before measurement using the Attenuated Total Reflection technique [75], potentially 
impacting significantly on the clinical workflow [76]. In the case of Raman spectroscopy, signal 
enhancement using nanoparticles or surface coatings is an active area of research [77]. 
Nevertheless, it has been demonstrated that quantitative evaluation of high and low molecular 
weight constituents [78–80], as well as exogenous factors such as viruses [81, 82] and 
chemotherapeutic agents [83] can be performed on blood serum, in its native aqueous state [84, 
85]. Concentration of samples using centrifugal filtration devices has been shown to allow 
measurement of the analytes in the native aqueous environment [86]. This also allows fractionation 
according to molecular weight of the constituent analytes, potentially allowing the targeting of 
molecular biomarkers of a disease.  
Raman spectroscopic analysis of blood samples has also been applied to oral cancer diagnostics. It 
has been demonstrated that serum samples from patients that had been diagnosed with buccal 
mucosa and tongue cancer can be distinguished from those from healthy volunteers [87]. Amino 
acids and lipids were the most significant Raman bands identified in the analysis, and an efficacy of 
85% was determined. Raman spectroscopy of serum samples was also able to predict a potential 
reoccurrence of oral cancer [87]. 
In a study of urine samples of healthy subjects and oral cancer patients using Raman spectroscopy, it 
was demonstrated that the technique can provide diagnostic discrimination with an accuracy of 94% 
[88]. Voided raw urine was collected from 167 patients and spectroscopic evaluation revealed 
elevated intensities of features associated with uric acid, specifically C–C stretching at 558 and 649 
cm−1 and N–H stretching at 798 cm−1, in cancer patients compared to healthy volunteers. Four 
Raman bands related to creatinine also showed increases, while the band at 692 cm−1 was only 
present in cancer patients.  
Amongst biofluids, saliva has gained increasing interest as a diagnostic fluid, since it represents a 
non-invasive, safe and cheap source of complex biomolecular information which can easily be 
obtained from the oral cavity [89]. Whole saliva refers to the complex mixture of fluids from the 
salivary glands, the gingival crevice, oral mucosa transudate, in addition to mucus of the nasal cavity 
and pharynx, non-adherent oral bacteria, food debris, desquamated epithelial and blood cells. Saliva 
is composed of more than 99% water. Saliva also contains a variety of electrolytes, including sodium, 
potassium, calcium, magnesium, bicarbonate, and phosphates. Also found in saliva are 
immunoglobulins, proteins, enzymes, mucins, and nitrogenous products, such as urea and ammonia 
[90]. Recent years have seen the development of salivary diagnostic tools to potentially monitor 
various oral diseases, ranging from periodontal diseases, dental caries to infections and autoimmune 
diseases, although saliva may be used not only to potentially detect oral diseases but also systemic 
ones, showing versatility and merit in diagnostic scope. Salivary biomarkers have already shown 
promising results in the diagnosis of many diseases, such as periodontitis [91], HIV [92], Hepatitis B 
[93], and even measles [94]. Immunoassays have been developed to detect secretory IgA and serum-
derived IgG (from crevicular fluid) found in saliva for various diseases, as well as saliva has shown 
potential for hormone and drug screening [95]. 
A systematic review of the literature on vibrational spectroscopic analysis of saliva for diagnostic 
applications was recently performed by Derruau et al. [96–103]. Of the identified relevant studies, 
those relating to oral pathologies were exclusively studied by Raman spectroscopy, and a slightly 
earlier review of the literature reporting analysis of saliva samples for the diagnosis of oral cancer by 
Calado et al. [104] revealed the literature to be very sparse, and that the majority of studies to date 
have been carried out using Surface Enhanced Raman scattering techniques [94]. Values of 
sensitivity, specificity and/or classification efficiency higher than 90% were demonstrated for the 
diagnosis of OSCC. Peaks/bands associated with salivary components such as proteins, glycoproteins 
and lipids were variably identified as potentially associated with the presence of OSCC/oral epithelial 
dysplasia in all the studies reviewed. A more recent study examined different sampling 
methodologies, including air-dried, lyophilised, pellet and supernatant sampling, and concluded that 
the former two forms may be more appropriate for saliva sampling [95]. The method was tested for 
classification of oral cancer and healthy subjects (n= 27), yielding 90 % differentiation efficiency. 
Notable in the reviews of Derruau et al. [105] and Calado et al. [105] is the inconsistency of the 
methodologies employed to date, particularly with regard to the sample collection process. Saliva 
can be either stimulated (e.g. by mastication) or non-stimulated, and the contribution of each 
salivary gland to, and therefore the average compositions of, each can vary significantly. Raman 
analysis of stimulated and non-stimulated saliva from the same donors, however, confirms the 
significance of the different compositions [105]. In terms of clinical workflow, however, collection 
times for non stimulated saliva (10-15 minutes) are significantly longer than those for stimulated 
saliva (2-3 minutes), and so the latter methodology is more favourable for translation to the clinic, 
and was utilised for a proof-of-concept study exploring Raman spectroscopy for identification of 
OPMDs and OSCC [105]. In a study of saliva samples of 45 OPMD/OSCC patients and 45 normal 
volunteer donors, a binary comparison using PLSDA resulted in a sensitivity and specificity of 86% 
and 89%, respectively. Efforts to classify the OPMDs vs OSCC groups, and mild/moderate/severe 
dysplasia subgroups of OPMD, resulted in significantly lower sensitivity/specificity, although it 
should be noted that, as the patient numbers were rather limited, and even more so when 
subdivided into grades, the analysis was necessarily performed on very imbalanced data pairs of 
subsets which can impact the data analysis protocol. However, using a randomised selection process 
to balance the datasets, sensitivity and specificity of 75% and 72% were achieved for classification of 
the OPMDs vs OSCC groups [106]. The influence of patient factors and potential confounding factors 
on the Raman spectroscopic classification through saliva analysis was also explored in the same 
dataset. Partial least squares discriminant analysis did not show any statistical influence of the 
gender, age profile or alcohol consumption habits of the groups, although it was noticeable that the 
smoker control and patient groups seemed to exhibit a high degree of misclassification, which could 
represent a possible confounding factor for the misdiagnosis of smokers as having dysplasia [30].  
5. In Vivo: 
Although IR spectroscopy provides a detailed fingerprint of the biochemical content of a sample, it 
has predominantly been used for the analysis of human tissues ex vivo. Its application to in vivo 
diagnosis is limited, because of the short penetration depth and the relatively strong IR absorption 
of water in both the fingerprint (~1640 cm-1) and high wavenumber (~3200-3300 cm-1) regions of the 
spectrum. Conventional optical fibers have limited transparency in the infrared region, and, although 
mid-infrared probes have been explored for in vivo applications [107], Raman spectroscopy is 
generally considered a more favourable option for in vivo applications [108]. Using fiber optic 
probes, Guze et al. undertook an in vivo Raman spectroscopy study to establish whether the 
spectroscopic signatures of normal oral mucosa are reproducible across different anatomic sites and 
subjects of different race and gender [109]. Spectroscopic sampling of the; buccal mucosa, gingiva, 
dorsal and ventral surfaces of the tongue, floor of the mouth, mucosa of the lower lip, and hard 
palate, indicated that different sites are differentiated on the basis of degree of keratinisation. 
Bergholt et al. [110] performed a more detailed characterisation of the in vivo Raman spectroscopic 
profiles of a similar range of anatomical regions, fitting of the spectra with those of reference 
biochemical constituents. The study concluded that the histological and morphological 
characteristics of the different sites have a significant influence on the in vivo Raman profiles, and 
demonstrated, using partial least squares-discriminant analysis, that the different sites can be 
classified with an accuracy of ~85%. Sahu et al. [111] demonstrated that in vivo Raman spectroscopy 
methods can also be utilised to understand age-related changes in the oral mucosa. Singh et al. [112] 
verified that such in vivo analyses can be performed within clinically feasible timeframes and notably 
the potential to differentiate normal and pathologically abnormal regions was demonstrated, 
despite the anatomical variability [113], while a further study explored tobacco-induced cancer field 
effects in the oral mucosa [114].  
Inadequate resection margins in oral cancer surgery increase the likelihood of local recurrence [50]. 
The use of Raman spectroscopy as an aid in delineation of surgical margins has been explored 
extensively in recent years [115], and notably it has been shown that OSCC can be discriminated 
from surrounding normal structures with a high degree of accuracy, although it is more likely to 
misclassify with surrounding normal and dysplastic epithelium [116]. Water concentration was found 
to be higher in tumours compared to the surrounding normal tissue, therefore potentially acting as 
an in vivo guide to surgical resection [117]. An in-vivo study by Malik et al. even found that Raman 
spectroscopy can predict local recurrence in oral cancers with a sensitivity of 80% and specificity of 
30% [118]. 
6. Discussion and Future Perspectives 
In the various areas of potential clinical application, vibrational spectroscopies have been 
demonstrated to hold much promise in the identification, diagnosis and treatment of oral cancers, at 
least at the proof of concept level. In addition to identification of the presence of disease, the 
techniques can potentially differentiate between high grade (moderate/severe dysplasia) and low 
grade (no/mild dysplasia) lesions, and between dysplasia and inflammation. It is important to 
consider, however, the relative merits of the techniques, and the potential for achieving their 
translation. In all cases, both IR absorption and Raman spectroscopies offer the benefits of being 
label free, non destructive, and capable of delivering an objective analysis which is based on the 
biomolecular composition of the sample, which can be manifest at the early stages of the disease 
development, rather than morphological changes, the assessment of which can be subjective, and 
manifest only at the later stages of disease progression. 
In the case of analysis of tissue biopsies, imaging or mapping of considerably large areas is required, 
which is time consuming, and computationally intensive. The former consideration probably favours 
the use of IR absorption techniques. The incorporation of Focal Plane Array detectors in FTIR 
microscopes enables the simultaneous acquisition of several thousands of spectra [119] and the 
more recent emergence of tuneable IR quantum cascade laser spectrometer systems potentially 
offers a further step change in data acquisition and processing speeds, which renders the feasibility 
of rapid screening of large tissue areas more credible [120]. In comparison, the lower spatial 
resolution and/or challenge of the relatively low signal to noise of Raman microspectroscopy makes 
it difficult for the technique to rapidly screen large areas. Notably, however, the similarly emerging 
techniques of Coherent Raman Scattering (CRS) [121] provide enhancement of signals by several 
orders of magnitude and are capable of rapid 3D mapping of bio-molecules with sub-micron 
resolution [122]. CRS microscopy can be implemented by recording the coherent anti-Stokes Raman 
scattering (CARS) or stimulated Raman scattering (SRS) signal, and both modalities have been 
explored for clinical and biological studies[123], including rapid, in-situ label-free acquisition of H&E 
like images based on the ratio of Raman signals at 2930 and 2845 cm-1, reflecting the different lipid 
and protein contents [124]. The debate on the relative merits of the two techniques for rapid 
screening of histological samples continues, therefore. An important consideration in the 
applications of such label free techniques to tissue based diagnostics, however, is the observation of 
confounding factors of inflammation in the connective tissue, smoking status, and anatomical site. 
The higher intrinsic spatial resolution of Raman microspectroscopy makes it more amenable to the 
less invasive cytological applications, and the methodologies based on exfoliated cells are readily 
adaptable from cervical cytology, which is well established in clinical screening programmes 
internationally, with minimal interruption of workflow [125]. The subcellular regions of nucleus and 
cytoplasm can be interrogated independently, and it has been observed that they afford 
comparable, high degrees of sensitivity and specificity of diagnosis [86]. Cytological based diagnosis 
can notoriously lead to false negative results, due to the sparsity of morphologically abnormal cells 
on the slide, and consequently low sensitivities [126]. Critically, however, in both cervical [76] and 
oral [86] cytological samples, it has been demonstrated that morphologically normal cells exhibit 
abnormal Raman spectroscopic signatures which can be associated with early onset of disease, 
resulting in significantly increased sensitivities compared to morphologically based cytological 
diagnostic tests. Anatomical site was seen to be the most obvious potential confounding factor, but 
it was argued that independent multivariate prediction models can be constructed for keratinised 
and non-keratinised anatomical regions. The ability to detect and identify field cancerisation 
presents the possibility to predict the recurrence of multiple lesions. 
Saliva represents an even less invasive “liquid biopsy” which shows potential for oral cancer 
diagnostics, and can readily be probed using either IR or Raman spectroscopy. The differences in 
diagnostic potential of stimulated and non-stimulated saliva samples has to date not fully been 
explored, and critically the relative influences of systemic or localised oral disease on their 
biochemical compositions, which could compromise the specificity of the diagnosis, is not yet clear. 
Within the context of the increasing application of vibrational spectroscopic techniques for 
diagnostic screening of biofluids, IR has the disadvantage that the requirement of drying can 
interrupt the clinical workflow [76], although Raman analysis of biofluids also commonly employs a 
concentration step, for example through centrifugal filtration [86]. 
In terms of computational aspects, histopathological applications are probably the most demanding. 
Both IR and Raman mapping can generate large datasets, the recording, preprocessing and analysis 
of which can take hours [125]. For all applications, however, once a reference database to establish 
a predictive model has been, comparative screening of an individual sample is relatively rapid, and 
“chairside” in vitro analysis could potentially be performed in quasi realtime. In the case of either 
cytological or biofluid based diagnostic applications, a real significant impact would be the ability to 
implement the screening in vivo, or “chairside”, as part of a routine dental or oral hygiene check-up, 
or post treatment follow up clinics. In terms of initial capital costs, this makes ATR-FTIR a more 
attractive alternative to that of Raman. Nevertheless, more compact, less expensive, but 
high specification Raman microscopic systems for cytological applications are becoming 
increasingly available, and significantly lower cost fiber based options may be a viable 
alternative for biofluid analysis, reducing capital costs to ~€10-20k, comparable to those of 
compact ATR-FTIR instruments. Of course, the ability of such systems to provide sufficient 
sensitivity and specificity would potentially enable routine chairside in vivo screening of oral 
lesions and the requirement for invasive biopsies could be reduced. This technology could also 
be used to assist in directing the clinician to the most appropriate biopsy site in the case of extensive 
oral lesions or for intra-operative assessment of surgical margins.  
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